Allevi
Acquired3D bioprinting for researchers and scientists
United States · $2.8M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- www.allevi3d.com
- Total Funding
- $2.8M
- Last Round
- $2.0M Series AOct 2019
- Rounds
- 3
About
Allevi designed and manufactured bioprinters and bioinks for researchers working in tissue engineering, drug testing, and regenerative medicine. Based in Philadelphia, the company's 3D bioprinting systems were used by academic labs and pharmaceutical teams to print living tissue models. Allevi was acquired by 3D Systems and discontinued bioprinter production in July 2023.
Summary
Allevi is a Biotech company based in United States. It has raised $2.8M in total across 3 rounds, most recently a $2.0M Series A round in Oct 2019. Investors include Alumni Ventures, Space Angels and Y Combinator Continuity Fund.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2021
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.